LIVN
LivaNova PLCNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$3.47B
P/E Ratio
—
EPS
$-4.45
Beta
0.97
52W High
$71.92
52W Low
$32.65
50-Day MA
$64.88
200-Day MA
$56.85
Dividend Yield
—
Profit Margin
-17.50%
Forward P/E
15.15
PEG Ratio
0.73
About LivaNova PLC
LivaNova PLC, a medical device company, designs, develops, manufactures and sells therapeutic solutions globally. The company is headquartered in London, the United Kingdom.
Fundamentals
| Revenue (TTM) | $1.39B |
| Gross Profit (TTM) | $944.07M |
| EBITDA | $257.65M |
| Operating Margin | 13.00% |
| Return on Equity | -19.20% |
| Return on Assets | 5.17% |
| Revenue/Share (TTM) | $25.45 |
| Book Value | $21.96 |
| Price-to-Book | 2.91 |
| Price-to-Sales (TTM) | 2.50 |
| EV/Revenue | 2.369 |
| EV/EBITDA | 10.69 |
| Quarterly Earnings Growth (YoY) | -45.60% |
| Quarterly Revenue Growth (YoY) | 12.10% |
| Shares Outstanding | $54.69M |
| Float | $50.96M |
| % Insiders | 0.39% |
| % Institutions | 107.01% |
Analyst Ratings
Consensus ($79.91 target)
2
Strong Buy6
Buy3
HoldData last updated: 4/8/2026